February 23, 2008 -- QIAGEN (NSDQ: QGEN) established an Asia-Pacific Service Solutions Center in Singapore to service clients in the area; NovaSecta, a UK company that advises European biopharmas on R&D matters, has formed an alliance with Sundia MediTech and HD BioSciences; Omnicare Clinical Research opened two offices in China; RHEI Pharmaceuticals in-licensed China rights for ADHD nutraceutical Attental from MethaPharma; two publicly traded Japanese drug wholesalers will establish JVs to bring drugs to China; Beijing Med-Pharm (NSDQ: BJGP) completed its acquisition of Sunstone Pharma; Shanghai Century Acquisition (AMEX: SHA) ended its attempt to buy Sichuan Kelun Pharma; and 3SBio Inc. (NDSQ: SSRX) reported higher revenues and earnings in its fourth quarter, but the results still fell short of estimates. More details...
